A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
A teenage survivor from the Manchester Arena bombing is among the acts through to the Britain's Got Talent semi-finals.
Your grass pollen forecast for the next few days...
Mostly dry with warm sunny spells, but a risk of thundery showers to southwestern fringes during Sunday